Clinical trial · Interventional
Extended Reality (XR)-Assisted CT Localization of Pulmonary Nodules
NCT07434167CI-TRIAL-00104015not yet recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Extended Reality (XR)-Assisted CT Localization of Pulmonary Nodules
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Extended Reality (XR) | — | UNRESOLVED | — |
| Lung Cancers | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
| Metaverse | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Extended Reality (XR)-Assisted CT Localization of Pulmonary Nodules | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Extended Reality (XR)-Assisted CT Localization of Pulmonary Nodules
- interventionNames
- Procedure: Extended Reality (XR)-Assisted CT Localization of Pulmonary Nodules
Primary outcomes (1)
- measure
- Localization accuracy
- timeFrame
- Immediatedly after Extended Reality (XR)-Assisted CT-Guided Localization
- description
- Procedures in this study will be conducted in a CT room. The accuracy of XR-assisted CT-guided localization will be assessed immediately after localization by employing in-room CT to determine the needle tip position and measure the distance to the target tumor.
Secondary outcomes (1)
- measure
- Assessment of perioperative outcomes
- timeFrame
- The study assessment time frame from XR-assisted CT-guided localization to discharge is approximately 3 to 7 days.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Patients aged between 18 and 80 who are scheduled to undergo lung nodule resection surgery. * Patients with lung nodules smaller than 2 cm that require preoperative localization. * Patients with lung nodules located in the outer one-third of the lung. Exclusion Criteria: * Patients requiring lobectomy. * Patients who have not provided written informed consent. * Vulnerable populations.
References
Publications (0)
Data not yet available
No reference posted for this study.